MCL1 and non-small cell lung carcinoma: But since ABT-737 antagonizes Bcl-2 and Bcl-xL, but not Mcl-1, which is overexpressed, among others in NSCLC [574], the effect of this BH3 mimetic is limited, unless combined with a drug reducing Mcl-1 expression.